Allspring Global Investments
RAPT

Allspring Global Investments’s RAPT Therapeutics RAPT Stock Holding History

Allspring Global Investments’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-114
Closed -$2.79K – 2564
2024
Q2 		$2.79K Buy
+114
New +$5.27K ﹤0.01% 2265
2023
Q3 		– Sell
-44
Closed -$6.53K – 2873
2023
Q2 		$6.53K Buy
+44
New +$6.85K ﹤0.01% 2567
2022
Q4 		– Sell
-7
Closed -$1K – 2944
2022
Q3 		$1K Sell
7
-112
-94% -$21.2K ﹤0.01% 2856
2022
Q2 		$17K Sell
119
-489
-80% -$65.2K ﹤0.01% 2523
2022
Q1 		$106K Buy
608
+65
+12% +$12.3K ﹤0.01% 2739
2021
Q4 		$159K Buy
+543
New +$145K ﹤0.01% 2684

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Allspring Global Investments's RAPT Position: Q3 2024 in Review

Allspring Global Investments sold out of RAPT Therapeutics (RAPT) in Q3 2024, closing a stake of 114 shares — an estimated $2.79K sold.

Allspring Global Investments first reported a position in RAPT in Q4 2021 and held it in 6 quarters. The position peaked at $159K in Q4 2021. 94 funds tracked by Wall St. Rank hold RAPT as of Q3 2024.

  • Allspring Global Investments reported no remaining RAPT Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 114 RAPT Therapeutics shares in Q3 2024, an estimated $2.79K.
  • Allspring Global Investments first reported a position in RAPT Therapeutics in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's RAPT Therapeutics position peaked at $159K in Q4 2021.
  • 94 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.